KA HELE1
pili ana

E pili ana i kā mākou hui

He aha kā mākou e hana ai?

Ua hoʻokumu ʻia ka hui ma 1969. ʻO ia ka Jiangxi Branch o ka Shanghai Institute of Biological Products of the Ministry of Health.Loaʻa iā ia ma kahi o 50 mau makahiki o ka mōʻaukala biopharmaceutical.I ka makahiki 2002, ua hoʻoponopono hou ʻia ʻo ia i ʻoihana liʻiliʻi.I ka makahiki 2017, ua hoʻokō ʻo ia i ka hoʻololi ʻana i ka ʻōnaehana ʻāpana.ʻO ia ka ʻoihana kiʻekiʻe kiʻekiʻe kiʻekiʻe ma Kina e loea i ka noiʻi, hana a kūʻai aku i nā huahana anti-toxin a me ka immune serum biological.

ʻO nā huahana nui o ka hui he tetanus antitoxin (immunoglobulin), serum lio hāpai;nā lawelawe hoʻolaha biotechnology.Me nā patent kūʻokoʻa kūʻokoʻa e hoʻopiha ai i ke āpau o ka home, ua lanakila nā huahana alakaʻi i ka "Seventh ASEAN Chinese Medicine Academic Conference Gold Award a me Jiangxi Province Excellent New Product".

nānā hou aku

Nā huahana wela

ʻO kā mākou huahana

E hoʻokaʻaʻike mai iā mākou no nā laʻana album hou

E like me kāu mau pono, hoʻopilikino iā ʻoe, a hāʻawi iā ʻoe i ke akamai

NINAU ANO
ico

ʻIke hou loa

nūhou

ico

Ua hoʻonui ka ʻoihana biopharmaceutical o Kina i kona piʻi ʻana i "ikaika hoʻokele hou" no ka ulu mau.

I loko o ka hale hana hana biopharmaceutical hou o Qilu Pharmaceutical Group Co., Ltd. aia ma Jinan, Shandong, ʻo ka lāʻau biosimilar biosimilar bevacizumab mua o koʻu ʻāina, ʻo Anke, i ka hana piha.ʻO kēia lāʻau lapaʻau, ka mea i hoʻohana nui ʻia no ka mālama ʻana i ka holomua, metastatic a i ʻole nā ​​​​mea liʻiliʻi ...

ʻO ka hui pū ʻana o Kina-India, kuʻikahi ikaika, nā manaʻo maikaʻi no ke kūlana hoʻoiho

Mai Iune 10th a 13th, 2012, ua hele mai ʻelua mau loea mai India's First Serum Research Institute i kā mākou hale hana ma lalo o ke alakaʻi ʻana o ka Luna Nui Ren o Ningbo Agency e hana i nā hoʻololi ʻenehana ma ke kaʻina hana TAT a me ka hui pū ʻana i nā huahana hou.Luna Nui Yao Xiaodong p...